Benzothiazole [EPC]

Benzothiazole [EPC] was reported 2224 times

Drugs of the Benzothiazole [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INSPIRATORY CAPACITY INCREASED 1 0.5000
1 HANDL SYNDROME 1 0.3333
2 COXIELLA TEST POSITIVE 1 0.2500
3 CERVICAL SPINAL CORD PARALYSIS 2 0.0952
4 CSF CELL COUNT ABNORMAL 2 0.0909
5 ANALGESIC INTERVENTION SUPPORTIVE THERAPY 1 0.0833
6 CSF GLUCOSE ABNORMAL 2 0.0833
7 ADJACENT SEGMENT DEGENERATION 2 0.0800
8 PROGRESSIVE BULBAR PALSY 2 0.0625
9 ANOREXIA AND BULIMIA SYNDROME 1 0.0625
10 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST 1 0.0588
11 POST PROCEDURAL COMPLICATION CIRCULATORY 1 0.0526
12 AMYOTROPHIC LATERAL SCLEROSIS 92 0.0427
13 TONGUE ATROPHY 2 0.0408
14 HAEMORRHAGIC NECROTIC PANCREATITIS 3 0.0400
15 DOPAMINE AGONIST WITHDRAWAL SYNDROME 2 0.0370
16 MOTOR NEURONE DISEASE 18 0.0370
17 ECTOPIC ATRIAL RHYTHM 1 0.0312
18 ANORECTAL VARICES HAEMORRHAGE 1 0.0312
19 HIPPOCAMPAL ATROPHY 1 0.0303
20 MUCOSAL IRRITATION 1 0.0303
21 DISSOCIATIVE FUGUE 2 0.0299
22 MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA 1 0.0294
23 HEREDITARY ATAXIA 1 0.0286
24 CSF RED BLOOD CELL COUNT POSITIVE 1 0.0286
25 ELECTROCARDIOGRAM ST SEGMENT 1 0.0278
26 DURAL TEAR 2 0.0256
27 CATHETER SITE HYPERSENSITIVITY 1 0.0250
28 NASOPHARYNGEAL REFLUX 1 0.0244
29 NEUROPSYCHOLOGICAL TEST ABNORMAL 1 0.0233
30 CSF PROTEIN ABNORMAL 1 0.0217
31 PSEUDOCYST 7 0.0217
32 CSF CELL COUNT INCREASED 3 0.0203
33 ARRHYTHMIA INDUCED CARDIOMYOPATHY 1 0.0189
34 CORNEAL ULCER 1 0.0172
35 HEPATIC INFILTRATION EOSINOPHILIC 1 0.0164
36 CSF WHITE BLOOD CELL COUNT INCREASED 3 0.0157
37 CYSTATIN C INCREASED 2 0.0156
38 ASSISTED SUICIDE 1 0.0143
39 CSF VIRUS IDENTIFIED 1 0.0143
40 FEEDING TUBE COMPLICATION 4 0.0129
41 OVERFLOW DIARRHOEA 1 0.0125
42 PANCREATITIS RELAPSING 10 0.0122
43 NONINFECTIOUS MYELITIS 1 0.0122
44 GASTROSTOMY 17 0.0110
45 ALPHA TUMOUR NECROSIS FACTOR INCREASED 1 0.0108
46 PANCREATIC ENZYME ABNORMALITY 1 0.0098
47 CSF PROTEIN INCREASED 8 0.0097
48 DEPERSONALISATION 8 0.0096
49 GAIT DEVIATION 1 0.0093
50 PRODUCT INTOLERANCE 2 0.0090
51 PSEUDARTHROSIS 2 0.0087
52 PHARYNGEAL HYPOAESTHESIA 8 0.0086
53 BENIGN UTERINE NEOPLASM 1 0.0085
54 NECROTISING OESOPHAGITIS 4 0.0080
55 MENOPAUSAL DISORDER 1 0.0078
56 BREATH SOUNDS 1 0.0073
57 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 1 0.0070
58 PANCREATITIS NECROTISING 16 0.0070
59 CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE 1 0.0068
60 PANCREATITIS HAEMORRHAGIC 3 0.0065
61 PNEUMONIA CHLAMYDIAL 1 0.0064
62 KERATITIS BACTERIAL 1 0.0061
63 DYSDIADOCHOKINESIS 1 0.0058
64 HAEMOGLOBINAEMIA 1 0.0058
65 BONE MARROW MYELOGRAM ABNORMAL 1 0.0057
66 MULTIFOCAL MOTOR NEUROPATHY 1 0.0057
67 PORTAL VEIN THROMBOSIS 18 0.0056
68 FEEDING TUBE USER 2 0.0055
69 BACTERIA STOOL IDENTIFIED 1 0.0053
70 GASTROSTOMY TUBE INSERTION 1 0.0052
71 EXCESSIVE GRANULATION TISSUE 4 0.0050
72 PERICARDITIS CONSTRICTIVE 2 0.0047
73 GRIP STRENGTH 1 0.0044
74 PARENTERAL NUTRITION 1 0.0043
75 NECROTISING SOFT TISSUE INFECTION 1 0.0043
76 APPLICATION SITE HYPOAESTHESIA 1 0.0043
77 AMNESTIC DISORDER 2 0.0041
78 PANCREATIC ENZYMES INCREASED 6 0.0041
79 INJECTION SITE STREAKING 1 0.0040
80 PHARYNGEAL PARAESTHESIA 6 0.0038
81 FISTULA REPAIR 1 0.0038
82 CSF PRESSURE INCREASED 1 0.0038
83 LYMPHOCYTE STIMULATION TEST POSITIVE 3 0.0037
84 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 3 0.0037
85 BULBAR PALSY 1 0.0036
86 GASTROINTESTINAL TUBE INSERTION 9 0.0036
87 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
88 BLOOD CREATINE DECREASED 1 0.0033
89 PROTEIN DEFICIENCY 1 0.0032
90 BLOOD OSMOLARITY DECREASED 2 0.0032
91 CORNEAL INFILTRATES 1 0.0032
92 BREAST CELLULITIS 1 0.0032
93 STAPHYLOCOCCAL ABSCESS 2 0.0031
94 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
95 INTRACRANIAL HYPOTENSION 2 0.0031
96 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
97 GENITAL INFECTION 1 0.0030
98 SPUTUM RETENTION 3 0.0030
99 POST CONCUSSION SYNDROME 1 0.0029
100 MARROW HYPERPLASIA 2 0.0029
101 PNEUMONITIS ASPIRATION 1 0.0029
102 POST LUMBAR PUNCTURE SYNDROME 3 0.0029
103 HYPOAESTHESIA ORAL 43 0.0028
104 NEUROMUSCULAR TOXICITY 1 0.0028
105 TONGUE PARALYSIS 2 0.0028
106 OBSESSIVE-COMPULSIVE SYMPTOM 1 0.0027
107 MECHANICAL VENTILATION 5 0.0026
108 PANCREATIC PSEUDOCYST 2 0.0026
109 POVERTY OF SPEECH 1 0.0026
110 DROPPED HEAD SYNDROME 1 0.0025
111 HOUSEBOUND 1 0.0025
112 LUNG DIFFUSION TEST DECREASED 1 0.0025
113 DEPENDENCE ON RESPIRATOR 1 0.0025
114 SKIN BACTERIAL INFECTION 2 0.0025
115 PROCEDURAL HEADACHE 1 0.0024
116 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
117 QUADRIPARESIS 4 0.0024
118 DYSPHORIA 12 0.0024
119 DEVICE CONNECTION ISSUE 5 0.0024
120 OROPHARYNGEAL SPASM 1 0.0024
121 TONGUE MOVEMENT DISTURBANCE 2 0.0023
122 MUSCLE CONTRACTIONS INVOLUNTARY 8 0.0023
123 BILIARY SEPSIS 1 0.0022
124 CATHETER SITE SWELLING 2 0.0021
125 BLOOD BICARBONATE INCREASED 1 0.0021
126 OPEN FRACTURE 1 0.0021
127 TRAUMATIC LUNG INJURY 4 0.0021
128 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
129 PRODUCT USE COMPLAINT 31 0.0020
130 BONE CANCER METASTATIC 1 0.0019
131 PALMOPLANTAR PUSTULOSIS 1 0.0019
132 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
133 AUTOSCOPY 1 0.0019
134 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
135 HYPERAMYLASAEMIA 1 0.0018
136 BLOOD MAGNESIUM ABNORMAL 1 0.0018
137 BLOOD PH INCREASED 1 0.0018
138 LUNG CONSOLIDATION 5 0.0018
139 OEDEMATOUS PANCREATITIS 1 0.0018
140 PARAESTHESIA ORAL 25 0.0017
141 EPIDIDYMITIS 2 0.0017
142 ALLODYNIA 2 0.0017
143 RESTRICTIVE PULMONARY DISEASE 2 0.0017
144 JAUNDICE CHOLESTATIC 6 0.0017
145 ANTEROGRADE AMNESIA 1 0.0017
146 DYSMETRIA 1 0.0017
147 PALATAL DISORDER 1 0.0017
148 PANCREATITIS ACUTE 37 0.0016
149 MYOPATHY TOXIC 1 0.0016
150 MEDICAL DEVICE SITE INFECTION 1 0.0016
151 MUSCLE ABSCESS 1 0.0016
152 WHITE BLOOD CELLS URINE POSITIVE 3 0.0016
153 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
154 MENINGITIS ASEPTIC 7 0.0016
155 NEUROPATHIC ARTHROPATHY 1 0.0015
156 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
157 RASH MORBILLIFORM 4 0.0014
158 FOREARM FRACTURE 1 0.0014
159 TRACHEOSTOMY 2 0.0014
160 LYMPHOCYTOSIS 3 0.0014
161 PRODUCT MONITORING ERROR 2 0.0014
162 BLOOD URIC ACID INCREASED 8 0.0014
163 FOREIGN BODY ASPIRATION 1 0.0014
164 CHLAMYDIAL INFECTION 1 0.0013
165 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
166 PULMONARY ARTERY THROMBOSIS 1 0.0013
167 PORTAL HYPERTENSION 4 0.0013
168 MYELITIS 2 0.0013
169 BILIRUBIN CONJUGATED INCREASED 3 0.0013
170 BLOOD FIBRINOGEN INCREASED 1 0.0013
171 PNEUMONIA MYCOPLASMAL 1 0.0013
172 HEAT EXHAUSTION 1 0.0012
173 COLON CANCER METASTATIC 2 0.0012
174 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
175 COLLAPSE OF LUNG 1 0.0012
176 TROPONIN I INCREASED 2 0.0012
177 SALIVARY HYPERSECRETION 12 0.0012
178 AMAUROSIS 1 0.0012
179 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
180 CATHETER SITE PRURITUS 1 0.0011
181 RADICULOPATHY 3 0.0011
182 CEREBELLAR ATROPHY 1 0.0011
183 PULMONARY TOXICITY 8 0.0011
184 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
185 MENINGIOMA BENIGN 1 0.0011
186 PERONEAL NERVE PALSY 6 0.0011
187 MYELOPATHY 2 0.0011
188 CEREBELLAR ATAXIA 1 0.0010
189 INFUSION SITE NODULE 1 0.0010
190 IDIOSYNCRATIC DRUG REACTION 1 0.0010
191 CORONARY ARTERY THROMBOSIS 2 0.0010
192 BREAST ABSCESS 1 0.0010
193 ALVEOLITIS ALLERGIC 1 0.0010
194 INFUSION SITE DISCOMFORT 1 0.0010
195 PNEUMONIA ASPIRATION 24 0.0010
196 NASAL INFLAMMATION 1 0.0009
197 NEUROMYOPATHY 1 0.0009
198 GALLBLADDER ENLARGEMENT 1 0.0009
199 SPUTUM INCREASED 2 0.0009
200 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
201 PILOERECTION 1 0.0009
202 PULMONARY FUNCTION TEST DECREASED 4 0.0009
203 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
204 CATHETER SITE DISCHARGE 1 0.0009
205 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
206 DISEASE COMPLICATION 4 0.0009
207 PO2 DECREASED 1 0.0009
208 METHAEMOGLOBINAEMIA 2 0.0009
209 HEPATIC CYTOLYSIS 11 0.0009
210 ACUTE LUNG INJURY 1 0.0008
211 CHOLESTASIS 16 0.0008
212 RADIUS FRACTURE 2 0.0008
213 PROSTATIC OPERATION 1 0.0008
214 CHRONIC RESPIRATORY FAILURE 1 0.0008
215 SLOW SPEECH 2 0.0008
216 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
217 OTITIS EXTERNA 1 0.0008
218 DISEASE PROGRESSION 96 0.0008
219 ABDOMINAL TENDERNESS 4 0.0008
220 JOINT WARMTH 1 0.0008
221 SEDATION COMPLICATION 2 0.0008
222 HAEMOLYTIC ANAEMIA 7 0.0008
223 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
224 BILIARY OBSTRUCTION 1 0.0008
225 PROTEIN TOTAL ABNORMAL 1 0.0008
226 ENCEPHALITIS AUTOIMMUNE 1 0.0008
227 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
228 DEVICE MISUSE 1 0.0008
229 HERPES OPHTHALMIC 1 0.0008
230 BLOOD POTASSIUM ABNORMAL 2 0.0007
231 INTESTINAL DILATATION 1 0.0007
232 INTERSTITIAL LUNG DISEASE 36 0.0007
233 CALCULUS BLADDER 1 0.0007
234 INTESTINAL MASS 1 0.0007
235 ASPIRATION 8 0.0007
236 INFUSION SITE RASH 1 0.0007
237 ACUTE RESPIRATORY FAILURE 14 0.0007
238 RESPIRATION ABNORMAL 5 0.0007
239 CHOKING SENSATION 4 0.0007
240 CHOKING 14 0.0007
241 BRONCHIAL OBSTRUCTION 1 0.0007
242 PERIPHERAL ARTERY OCCLUSION 1 0.0007
243 MYELITIS TRANSVERSE 1 0.0007
244 PRERENAL FAILURE 1 0.0007
245 MUSCLE FATIGUE 3 0.0007
246 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
247 RESPIRATORY SYMPTOM 2 0.0007
248 RESPIRATORY FAILURE 51 0.0007
249 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
250 NORMOCYTIC ANAEMIA 1 0.0007
251 BLOOD CREATINE INCREASED 3 0.0007
252 ODYNOPHAGIA 4 0.0007
253 ATYPICAL PNEUMONIA 2 0.0007
254 PEMPHIGOID 5 0.0007
255 EMBOLISM VENOUS 2 0.0007
256 ONYCHOLYSIS 1 0.0006
257 FOREIGN BODY IN THROAT 2 0.0006
258 MUSCULAR WEAKNESS 71 0.0006
259 HYPOVENTILATION 2 0.0006
260 INJECTION SITE INFECTION 2 0.0006
261 HOSPICE CARE 6 0.0006
262 PATHOLOGICAL GAMBLING 1 0.0006
263 GASTRIC DILATATION 1 0.0006
264 ENTEROBACTER INFECTION 1 0.0006
265 POST PROCEDURAL HAEMATOMA 1 0.0006
266 TACHYPNOEA 8 0.0006
267 GAZE PALSY 1 0.0006
268 GLIOBLASTOMA 1 0.0006
269 BLADDER NEOPLASM 1 0.0006
270 MUSCLE RIGIDITY 7 0.0006
271 WOUND COMPLICATION 2 0.0006
272 MILIARIA 1 0.0006
273 TRISMUS 3 0.0006
274 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
275 APLASTIC ANAEMIA 3 0.0006
276 EAR PRURITUS 2 0.0006
277 INFUSION SITE DISCHARGE 1 0.0006
278 DEPRESSIVE SYMPTOM 2 0.0006
279 RETCHING 12 0.0006
280 PARAPARESIS 1 0.0006
281 HEPATIC ENZYME INCREASED 38 0.0006
282 POOR QUALITY SLEEP 12 0.0006
283 PNEUMOMEDIASTINUM 1 0.0006
284 MUSCLE ATROPHY 7 0.0006
285 MYDRIASIS 7 0.0005
286 LOBAR PNEUMONIA 1 0.0005
287 CATHETER SITE INFECTION 2 0.0005
288 LIP DISORDER 1 0.0005
289 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
290 HYPOREFLEXIA 1 0.0005
291 CONCOMITANT DISEASE PROGRESSION 1 0.0005
292 DECREASED INTEREST 3 0.0005
293 DIPLEGIA 1 0.0005
294 EMPYEMA 1 0.0005
295 EMPHYSEMA 5 0.0005
296 FOAMING AT MOUTH 1 0.0005
297 CHANGE OF BOWEL HABIT 1 0.0005
298 HYPERBILIRUBINAEMIA 5 0.0005
299 DYSARTHRIA 18 0.0005
300 NEUROGENIC BLADDER 1 0.0005
301 TONGUE DISCOMFORT 2 0.0005
302 POOR PERIPHERAL CIRCULATION 2 0.0005
303 HEPATIC PAIN 2 0.0005
304 CATHETER SITE ERYTHEMA 1 0.0005
305 OCULOGYRIC CRISIS 1 0.0005
306 DYSPHAGIA 44 0.0005
307 PERIODONTITIS 1 0.0005
308 HEPATITIS ACUTE 3 0.0005
309 TONGUE DISCOLOURATION 2 0.0005
310 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
311 FAECES PALE 1 0.0004
312 PAPILLOEDEMA 2 0.0004
313 PERIARTHRITIS 1 0.0004
314 DISLOCATION OF VERTEBRA 1 0.0004
315 ENCEPHALITIS 3 0.0004
316 INFUSION SITE INFECTION 1 0.0004
317 MENOPAUSAL SYMPTOMS 1 0.0004
318 COLORECTAL CANCER METASTATIC 1 0.0004
319 INTENTIONAL DOSE OMISSION 12 0.0004
320 ORAL INTAKE REDUCED 1 0.0004
321 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
322 BREATH ODOUR 1 0.0004
323 HAEMATOLOGICAL INFECTION 1 0.0004
324 ENCEPHALOPATHY 10 0.0004
325 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
326 MUSCLE SPASTICITY 5 0.0004
327 ABDOMINAL DISCOMFORT 68 0.0004
328 MUCOUS STOOLS 2 0.0004
329 RESPIRATORY DISORDER 12 0.0004
330 INCREASED BRONCHIAL SECRETION 1 0.0004
331 INCREASED UPPER AIRWAY SECRETION 2 0.0004
332 UNRESPONSIVE TO STIMULI 10 0.0004
333 CATHETER SITE PAIN 1 0.0004
334 LUNG OPACITY 1 0.0004
335 DEATH 322 0.0004
336 ABDOMINAL MASS 1 0.0004
337 HYPONATRAEMIA 21 0.0004
338 BLOOD SODIUM INCREASED 1 0.0004
339 LIP BLISTER 1 0.0004
340 CLUMSINESS 1 0.0004
341 ABNORMAL FAECES 3 0.0004
342 CLONUS 1 0.0004
343 INTRACRANIAL PRESSURE INCREASED 2 0.0004
344 APHONIA 5 0.0004
345 ENDOTRACHEAL INTUBATION 1 0.0004
346 GENERALISED ERYTHEMA 2 0.0004
347 MICTURITION URGENCY 4 0.0003
348 MYOCARDITIS 4 0.0003
349 PHARYNGEAL DISORDER 1 0.0003
350 MOUTH SWELLING 2 0.0003
351 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
352 DYSPNOEA AT REST 1 0.0003
353 STRESS CARDIOMYOPATHY 2 0.0003
354 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
355 PANCREATITIS 18 0.0003
356 DEPRESSED MOOD 18 0.0003
357 LUNG INFILTRATION 3 0.0003
358 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
359 FLATULENCE 19 0.0003
360 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
361 OROPHARYNGEAL DISCOMFORT 3 0.0003
362 CENTRAL VENOUS CATHETERISATION 1 0.0003
363 LIVER FUNCTION TEST INCREASED 7 0.0003
364 DUODENITIS 1 0.0003
365 SPEECH DISORDER 17 0.0003
366 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
367 ADVERSE DRUG REACTION 29 0.0003
368 AGRANULOCYTOSIS 6 0.0003
369 ILEUS 4 0.0003
370 INFUSION SITE EXTRAVASATION 2 0.0003
371 THERAPY PARTIAL RESPONDER 5 0.0003
372 INFUSION SITE PRURITUS 1 0.0003
373 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
374 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
375 ORTHOPNOEA 1 0.0003
376 ATELECTASIS 3 0.0003
377 PARKINSONISM 3 0.0003
378 POSTURE ABNORMAL 1 0.0003
379 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
380 PRODUCT PREPARATION ISSUE 2 0.0003
381 MUSCLE TWITCHING 7 0.0003
382 DYSGRAPHIA 2 0.0003
383 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
384 CORONAVIRUS INFECTION 2 0.0003
385 BLADDER DISORDER 3 0.0003
386 MENINGITIS 2 0.0003
387 BRONCHIECTASIS 2 0.0003
388 EUPHORIC MOOD 3 0.0003
389 INITIAL INSOMNIA 3 0.0003
390 NEPHROTIC SYNDROME 2 0.0003
391 POOR VENOUS ACCESS 3 0.0003
392 RESPIRATORY DISTRESS 8 0.0003
393 DROOLING 2 0.0003
394 BLOOD CREATININE ABNORMAL 1 0.0003
395 HYPOPNOEA 1 0.0003
396 ORAL DISCOMFORT 4 0.0003
397 DEVICE OCCLUSION 4 0.0003
398 INCONTINENCE 3 0.0003
399 NECROTISING FASCIITIS 1 0.0003
400 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
401 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
402 PRODUCT SUPPLY ISSUE 2 0.0003
403 DERMATITIS BULLOUS 2 0.0003
404 HYPOKINESIA 4 0.0003
405 GASTROENTERITIS 4 0.0003
406 MALNUTRITION 3 0.0003
407 IMPULSIVE BEHAVIOUR 1 0.0003
408 HEPATIC NECROSIS 1 0.0003
409 FACE INJURY 1 0.0003
410 COMMUNICATION DISORDER 1 0.0003
411 LIPASE INCREASED 2 0.0003
412 HYPOXIA 9 0.0003
413 OESOPHAGEAL PAIN 1 0.0003
414 PATENT DUCTUS ARTERIOSUS 1 0.0003
415 HYPERPHAGIA 1 0.0003
416 AZOTAEMIA 1 0.0003
417 MYASTHENIA GRAVIS 2 0.0002
418 FRUSTRATION TOLERANCE DECREASED 2 0.0002
419 TASTE DISORDER 5 0.0002
420 DECUBITUS ULCER 2 0.0002
421 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
422 ASPHYXIA 2 0.0002
423 GOITRE 1 0.0002
424 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
425 ACCIDENTAL EXPOSURE 1 0.0002
426 SECRETION DISCHARGE 3 0.0002
427 CANDIDA INFECTION 4 0.0002
428 LIP OEDEMA 1 0.0002
429 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
430 HYPOPHAGIA 6 0.0002
431 FACIAL PARALYSIS 2 0.0002
432 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
433 BALANCE DISORDER 20 0.0002
434 HEPATIC LESION 1 0.0002
435 OCULAR ICTERUS 1 0.0002
436 MONOPLEGIA 1 0.0002
437 ABDOMINAL PAIN UPPER 47 0.0002
438 EOSINOPHILIA 4 0.0002
439 HAEMORRHAGIC ANAEMIA 1 0.0002
440 GRIP STRENGTH DECREASED 2 0.0002
441 ABDOMINAL ABSCESS 1 0.0002
442 LIMB DISCOMFORT 7 0.0002
443 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
444 TRANSAMINASES INCREASED 5 0.0002
445 ANAL INCONTINENCE 2 0.0002
446 PRODUCT TASTE ABNORMAL 3 0.0002
447 PULMONARY EMBOLISM 21 0.0002
448 HAEMOGLOBIN INCREASED 1 0.0002
449 IMMUNE THROMBOCYTOPENIA 1 0.0002
450 EAR DISORDER 1 0.0002
451 ASTHENIA 82 0.0002
452 CHRONIC MYELOID LEUKAEMIA 1 0.0002
453 COORDINATION ABNORMAL 3 0.0002
454 DIARRHOEA 138 0.0002
455 SINUS TACHYCARDIA 3 0.0002
456 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
457 LOWER LIMB FRACTURE 4 0.0002
458 GUILLAIN-BARRE SYNDROME 1 0.0002
459 DYSPHONIA 12 0.0002
460 GASTROINTESTINAL DISORDER 18 0.0002
461 HAEMORRHAGE INTRACRANIAL 3 0.0002
462 GAIT DISTURBANCE 38 0.0002
463 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
464 CORONARY ARTERIAL STENT INSERTION 1 0.0002
465 NAUSEA 156 0.0002
466 PATHOLOGICAL FRACTURE 1 0.0002
467 OXYGEN SATURATION DECREASED 11 0.0002
468 PHLEBITIS 1 0.0002
469 DEVICE RELATED INFECTION 3 0.0002
470 THERAPY CESSATION 10 0.0002
471 FAILURE TO THRIVE 1 0.0002
472 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
473 HEAD INJURY 6 0.0002
474 PNEUMOTHORAX 3 0.0002
475 HEPATIC FUNCTION ABNORMAL 7 0.0002
476 JAUNDICE 5 0.0002
477 ANAL ABSCESS 1 0.0002
478 BEHAVIOUR DISORDER 1 0.0002
479 HYDROCEPHALUS 1 0.0002
480 CONSTIPATION 40 0.0002
481 WOUND INFECTION 2 0.0002
482 FAECALOMA 1 0.0002
483 ASTHENOPIA 1 0.0002
484 GASTROINTESTINAL PAIN 2 0.0002
485 DRUG LEVEL INCREASED 3 0.0002
486 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
487 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
488 URINARY RETENTION 6 0.0002
489 RASH MACULO-PAPULAR 4 0.0002
490 THROAT IRRITATION 8 0.0002
491 CHROMATURIA 4 0.0002
492 HEMIPARESIS 3 0.0002
493 STATUS EPILEPTICUS 2 0.0002
494 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
495 DRUG INTERACTION 28 0.0002
496 CHOLECYSTITIS ACUTE 1 0.0002
497 MYOCARDIAL ISCHAEMIA 2 0.0002
498 PARANOIA 3 0.0002
499 DECREASED APPETITE 40 0.0002
500 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
501 ENERGY INCREASED 1 0.0002
502 BRADYKINESIA 1 0.0002
503 AMNESIA 11 0.0002
504 ATAXIA 2 0.0002
505 PLEURISY 1 0.0002
506 CARDIAC PACEMAKER INSERTION 1 0.0002
507 CARDIO-RESPIRATORY ARREST 7 0.0002
508 HEPATITIS CHOLESTATIC 1 0.0002
509 LEUKOCYTOSIS 3 0.0002
510 APHASIA 5 0.0002
511 RESTLESS LEGS SYNDROME 3 0.0002
512 FOETAL GROWTH RESTRICTION 1 0.0002
513 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
514 CONDITION AGGRAVATED 49 0.0002
515 OLIGURIA 1 0.0002
516 PNEUMONIA 52 0.0002
517 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
518 BLOOD SODIUM DECREASED 3 0.0002
519 SOMNOLENCE 32 0.0002
520 INFUSION SITE SWELLING 1 0.0002
521 DIZZINESS 79 0.0002
522 PHOTOPSIA 1 0.0002
523 DYSPNOEA 89 0.0002
524 PULMONARY FIBROSIS 3 0.0002
525 HEPATITIS 4 0.0002
526 ENTERITIS 1 0.0002
527 ERUCTATION 3 0.0002
528 WEIGHT DECREASED 43 0.0002
529 FALL 51 0.0002
530 MOBILITY DECREASED 11 0.0002
531 SUICIDAL IDEATION 14 0.0002
532 BEDRIDDEN 2 0.0002
533 ORAL CANDIDIASIS 2 0.0002
534 PULMONARY CONGESTION 2 0.0002
535 STAPHYLOCOCCAL INFECTION 5 0.0002
536 ABDOMINAL PAIN 35 0.0002
537 SKIN DISORDER 5 0.0001
538 GAIT INABILITY 5 0.0001
539 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
540 PRODUCT ADMINISTRATION ERROR 3 0.0001
541 MUSCLE SPASMS 27 0.0001
542 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
543 TACHYCARDIA 13 0.0001
544 BLOOD TESTOSTERONE DECREASED 1 0.0001
545 ECCHYMOSIS 1 0.0001
546 ONYCHOCLASIS 1 0.0001
547 RHABDOMYOLYSIS 6 0.0001
548 POLLAKIURIA 6 0.0001
549 HYPERTRANSAMINASAEMIA 1 0.0001
550 ATRIAL FIBRILLATION 14 0.0001
551 FEELING COLD 4 0.0001
552 DEFAECATION URGENCY 1 0.0001
553 APPLICATION SITE REACTION 1 0.0001
554 SKIN REACTION 2 0.0001
555 LYMPHOPENIA 2 0.0001
556 EATING DISORDER 3 0.0001
557 FEAR OF INJECTION 1 0.0001
558 THERAPY INTERRUPTED 10 0.0001
559 AGGRESSION 7 0.0001
560 PARALYSIS 2 0.0001
561 HYPERSOMNIA 4 0.0001
562 IMPAIRED QUALITY OF LIFE 2 0.0001
563 LETHARGY 8 0.0001
564 DEEP VEIN THROMBOSIS 9 0.0001
565 FAECES DISCOLOURED 3 0.0001
566 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
567 FAECES SOFT 1 0.0001
568 NASAL CONGESTION 8 0.0001
569 PSYCHIATRIC SYMPTOM 1 0.0001
570 BLOOD PRESSURE DECREASED 9 0.0001
571 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
572 LIVER DISORDER 6 0.0001
573 ARTHROPOD BITE 1 0.0001
574 FEELING DRUNK 1 0.0001
575 SEPSIS 15 0.0001
576 PULMONARY MASS 2 0.0001
577 KETOACIDOSIS 1 0.0001
578 PRODUCT AVAILABILITY ISSUE 3 0.0001
579 DEVICE FAILURE 2 0.0001
580 BOWEL MOVEMENT IRREGULARITY 1 0.0001
581 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
582 DISSOCIATION 1 0.0001
583 PROCEDURAL COMPLICATION 1 0.0001
584 PHARYNGEAL OEDEMA 2 0.0001
585 PERIPHERAL SWELLING 20 0.0001
586 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
587 HAEMOLYSIS 1 0.0001
588 URINARY TRACT INFECTION 22 0.0001
589 HYPOALBUMINAEMIA 1 0.0001
590 APNOEA 1 0.0001
591 SWOLLEN TONGUE 4 0.0001
592 DRUG SCREEN POSITIVE 1 0.0001
593 NASAL DISCOMFORT 1 0.0001
594 PRODUCTIVE COUGH 6 0.0001
595 GINGIVAL PAIN 1 0.0001
596 ABSCESS 2 0.0001
597 ATRIAL FLUTTER 1 0.0001
598 DIABETIC KETOACIDOSIS 3 0.0001
599 ABDOMINAL DISTENSION 13 0.0001
600 LIVER INJURY 3 0.0001
601 DYSPEPSIA 12 0.0001
602 HICCUPS 1 0.0001
603 HYPERAESTHESIA 1 0.0001
604 AGEUSIA 3 0.0001
605 LIP SWELLING 4 0.0001
606 WITHDRAWAL SYNDROME 5 0.0001
607 INFUSION SITE ERYTHEMA 1 0.0001
608 FATIGUE 92 0.0001
609 PRODUCT USE ISSUE 22 0.0001
610 FEELING ABNORMAL 28 0.0001
611 PRODUCT CONTAINER ISSUE 1 0.0001
612 PSEUDOMONAS INFECTION 1 0.0001
613 RASH GENERALISED 3 0.0001
614 PLEURAL EFFUSION 7 0.0001
615 SEPTIC SHOCK 5 0.0001
616 MUSCULOSKELETAL PAIN 6 0.0001
617 PARAESTHESIA 18 0.0001
618 NEUROTOXICITY 2 0.0001
619 LYMPHOCYTE COUNT DECREASED 2 0.0001
620 BLOOD BILIRUBIN INCREASED 3 0.0001
621 HEART RATE INCREASED 11 0.0001
622 DRY MOUTH 9 0.0001
623 TOOTHACHE 2 0.0001
624 OPTIC NEURITIS 1 0.0001
625 PANIC ATTACK 4 0.0001
626 INTENTIONAL OVERDOSE 7 0.0001
627 INCREASED TENDENCY TO BRUISE 1 0.0001
628 PERSONALITY CHANGE 1 0.0001
629 HEPATIC STEATOSIS 2 0.0001
630 PANCYTOPENIA 6 0.0001
631 APPENDICITIS 1 0.0001
632 DIARRHOEA HAEMORRHAGIC 1 0.0001
633 COUGH 30 0.0001
634 ILLNESS 11 0.0001
635 VOMITING 50 0.0001
636 DYSPNOEA EXERTIONAL 4 0.0001
637 MUSCULOSKELETAL DISORDER 2 0.0001
638 COMA 5 0.0001
639 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
640 AFFECT LABILITY 1 0.0001
641 PRESCRIBED OVERDOSE 2 0.0001
642 DYSSTASIA 3 0.0001
643 MUSCULOSKELETAL STIFFNESS 9 0.0001
644 AUTOIMMUNE DISORDER 1 0.0001
645 DRUG WITHDRAWAL SYNDROME 9 0.0001
646 PHARYNGEAL SWELLING 1 0.0001
647 LUNG DISORDER 5 0.0001
648 HEPATOMEGALY 1 0.0001
649 LIGAMENT SPRAIN 1 0.0001
650 INABILITY TO AFFORD MEDICATION 1 0.0001
651 HYPOTONIA 1 0.0001
652 DRY THROAT 1 0.0001
653 BLOOD PRESSURE INCREASED 15 0.0001
654 EAR DISCOMFORT 1 0.0001
655 DRUG-INDUCED LIVER INJURY 3 0.0001
656 PRODUCT ODOUR ABNORMAL 1 0.0001
657 FULL BLOOD COUNT ABNORMAL 1 0.0001
658 CYSTITIS 3 0.0001
659 HEADACHE 59 0.0001
660 BREAST PAIN 1 0.0001
661 MALAISE 41 0.0001
662 HEREDITARY ANGIOEDEMA 1 0.0001
663 DRUG INTOLERANCE 9 0.0001
664 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
665 RASH PRURITIC 5 0.0001
666 BIPOLAR DISORDER 1 0.0001
667 BACK INJURY 1 0.0001
668 PRODUCT PRESCRIBING ISSUE 2 0.0001
669 ALOPECIA 18 0.0001
670 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
671 OESOPHAGITIS 1 0.0001
672 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
673 BLOOD GLUCOSE FLUCTUATION 1 0.0001
674 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
675 FOOT DEFORMITY 1 0.0001
676 DEHYDRATION 12 0.0001
677 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
678 HYPERTENSIVE CRISIS 1 0.0001
679 HEPATOTOXICITY 2 0.0001
680 ORAL PAIN 2 0.0001
681 SNEEZING 2 0.0001
682 OCULAR DISCOMFORT 1 0.0001
683 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
684 EYE INFECTION 1 0.0001
685 IMPAIRED DRIVING ABILITY 1 0.0001
686 DERMATITIS CONTACT 1 0.0001
687 NEPHROLITHIASIS 4 0.0001
688 TINNITUS 4 0.0001
689 NIGHTMARE 3 0.0001
690 HYPOKALAEMIA 4 0.0001
691 DELIRIUM 3 0.0001
692 HYPERSENSITIVITY 16 0.0001
693 ELECTROLYTE IMBALANCE 1 0.0001
694 LOSS OF CONSCIOUSNESS 11 0.0001
695 COGNITIVE DISORDER 4 0.0001
696 HEART RATE DECREASED 3 0.0001
697 HYPERHIDROSIS 11 0.0001
698 CHILLS 10 0.0001
699 INFLUENZA LIKE ILLNESS 7 0.0001
700 HOSPITALISATION 13 0.0001
701 TREMOR 14 0.0001
702 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
703 BACTERAEMIA 1 0.0001
704 PRODUCT PRESCRIBING ERROR 2 0.0001
705 CHOLECYSTITIS 1 0.0001
706 MYOCLONUS 1 0.0001
707 BLOOD GLUCOSE DECREASED 4 0.0001
708 SKIN EXFOLIATION 7 0.0001
709 DRUG EFFECT INCOMPLETE 3 0.0001
710 VERTIGO 5 0.0001
711 NO THERAPEUTIC RESPONSE 1 0.0001
712 PRODUCT DOSE OMISSION ISSUE 24 0.0001
713 HYPERCALCAEMIA 1 0.0001
714 ANXIETY 23 0.0001
715 PRURITUS 31 0.0001
716 PHARYNGITIS 1 0.0001
717 INTESTINAL OBSTRUCTION 3 0.0001
718 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
719 ANOREXIA 1 0.0001
720 RHINORRHOEA 5 0.0001
721 HAEMATOMA 2 0.0001
722 DIPLOPIA 2 0.0001
723 PLATELET COUNT INCREASED 1 0.0001
724 DRUG INEFFECTIVE 101 0.0001
725 PRODUCT DOSE OMISSION 5 0.0001
726 SEDATION 2 0.0001
727 JOINT STIFFNESS 2 0.0001
728 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
729 ABNORMAL BEHAVIOUR 3 0.0001
730 BRADYCARDIA 4 0.0001
731 ADVERSE REACTION 1 0.0001
732 FEAR 2 0.0001
733 OFF LABEL USE 65 0.0001
734 EXTRA DOSE ADMINISTERED 3 0.0001
735 FREQUENT BOWEL MOVEMENTS 2 0.0001
736 DYSKINESIA 3 0.0001
737 OEDEMA 4 0.0001
738 NEUTROPENIA 10 0.0001
739 HYPOAESTHESIA 11 0.0001
740 DRUG TOXICITY 1 0.0001
741 IMPAIRED GASTRIC EMPTYING 1 0.0001
742 PERIPHERAL COLDNESS 1 0.0001
743 CARDIAC ARREST 6 0.0001
744 RESPIRATORY ARREST 2 0.0001
745 MENTAL STATUS CHANGES 2 0.0001
746 COMPLETED SUICIDE 6 0.0001
747 HYPOMAGNESAEMIA 1 0.0001
748 NECK PAIN 4 0.0001
749 CARPAL TUNNEL SYNDROME 1 0.0001
750 INSOMNIA 19 0.0001
751 BURNING SENSATION 5 0.0001
752 BLOOD TEST ABNORMAL 1 0.0001
753 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
754 TARDIVE DYSKINESIA 2 0.0001
755 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
756 BRONCHOSPASM 1 0.0001
757 RED BLOOD CELL COUNT DECREASED 2 0.0001
758 PANCREATIC CARCINOMA 2 0.0001
759 ANOSMIA 1 0.0001
760 HYPERTHYROIDISM 1 0.0001
761 LIVER FUNCTION TEST ABNORMAL 2 0.0001
762 APATHY 1 0.0001
763 CHEST DISCOMFORT 7 0.0001
764 AGITATION 5 0.0001
765 BRONCHITIS 5 0.0001
766 URINARY INCONTINENCE 2 0.0001
767 THERAPY NON-RESPONDER 3 0.0001
768 BLOOD POTASSIUM DECREASED 2 0.0001
769 PYREXIA 23 0.0001
770 UNEVALUABLE EVENT 5 0.0001
771 SUICIDE ATTEMPT 4 0.0001
772 BLOOD COUNT ABNORMAL 1 0.0001
773 DEPRESSION 15 0.0001
774 EPILEPSY 2 0.0001
775 SKIN DISCOLOURATION 3 0.0001
776 MYALGIA 11 0.0001
777 ANKLE FRACTURE 1 0.0001
778 RASH 28 0.0001
779 BRAIN FOG 1 0.0001
780 ARRHYTHMIA 3 0.0001
781 HALLUCINATION, AUDITORY 1 0.0001
782 INFLUENZA 7 0.0001
783 MOVEMENT DISORDER 2 0.0001
784 MUSCLE TIGHTNESS 1 0.0001
785 BACK DISORDER 1 0.0001
786 CHOLELITHIASIS 2 0.0001
787 EYE DISORDER 2 0.0001
788 MANIA 1 0.0001
789 TREATMENT FAILURE 5 0.0001
790 VISUAL ACUITY REDUCED 2 0.0001
791 COAGULOPATHY 1 0.0001
792 BLOOD UREA INCREASED 1 0.0001
793 PERICARDITIS 1 0.0001
794 MUSCULOSKELETAL DISCOMFORT 1 0.0001
795 JOINT SWELLING 7 0.0001
796 PAIN IN EXTREMITY 17 0.0001
797 INTENTIONAL PRODUCT MISUSE 5 0.0001
798 AMENORRHOEA 1 0.0001
799 COVID-19 10 0.0001
800 HYPERTENSION 12 0.0001
801 LYMPHADENOPATHY 2 0.0001
802 HEAD DISCOMFORT 1 0.0001
803 BACK PAIN 13 0.0001
804 GOUT 1 0.0001
805 CONFUSIONAL STATE 9 0.0001
806 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
807 GASTROENTERITIS VIRAL 1 0.0001
808 PELVIC PAIN 1 0.0001
809 C-REACTIVE PROTEIN INCREASED 2 0.0001
810 HYPOTENSION 11 0.0001
811 DYSURIA 2 0.0001
812 DYSGEUSIA 4 0.0001
813 BACTERIAL INFECTION 1 0.0001
814 MIDDLE INSOMNIA 1 0.0001
815 ACNE 4 0.0001
816 FOOT FRACTURE 1 0.0001
817 BLOOD URINE PRESENT 1 0.0001
818 PROTEINURIA 1 0.0001
819 DIABETES MELLITUS 4 0.0001
820 DRY SKIN 7 0.0001
821 EYE IRRITATION 3 0.0001
822 DRUG PRESCRIBING ERROR 1 0.0001
823 SEIZURE 6 0.0001
824 DYSTONIA 1 0.0001
825 WHEEZING 3 0.0001
826 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
827 DISORIENTATION 2 0.0001
828 HAEMATOCRIT DECREASED 1 0.0001
829 COMPLICATION OF DEVICE INSERTION 1 0.0001
830 PRESCRIBED UNDERDOSE 1 0.0001
831 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
832 STOMATITIS 3 0.0000
833 FEEDING DISORDER 1 0.0000
834 OEDEMA PERIPHERAL 6 0.0000
835 FLUSHING 5 0.0000
836 DISCOMFORT 3 0.0000
837 NEUTROPHIL COUNT DECREASED 2 0.0000
838 BODY TEMPERATURE INCREASED 1 0.0000
839 PRODUCT PREPARATION ERROR 1 0.0000
840 DERMATITIS 1 0.0000
841 KNEE ARTHROPLASTY 1 0.0000
842 TOXICITY TO VARIOUS AGENTS 8 0.0000
843 HALLUCINATION, VISUAL 1 0.0000
844 ANAEMIA 9 0.0000
845 OSTEOARTHRITIS 2 0.0000
846 JOINT INJURY 1 0.0000
847 IMPAIRED WORK ABILITY 1 0.0000
848 HYPOACUSIS 2 0.0000
849 DEVICE DISLOCATION 2 0.0000
850 ACUTE KIDNEY INJURY 7 0.0000
851 MELAENA 1 0.0000
852 FEBRILE NEUTROPENIA 3 0.0000
853 THROMBOCYTOPENIA 5 0.0000
854 GLOSSODYNIA 1 0.0000
855 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
856 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
857 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
858 URTICARIA 7 0.0000
859 BLOOD PRESSURE FLUCTUATION 1 0.0000
860 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
861 HEPATIC CANCER 1 0.0000
862 PRESYNCOPE 1 0.0000
863 NEURALGIA 1 0.0000
864 CEREBRAL INFARCTION 1 0.0000
865 ABASIA 1 0.0000
866 HOT FLUSH 3 0.0000
867 CELLULITIS 2 0.0000
868 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
869 GASTRIC CANCER 1 0.0000
870 PRODUCT COMPLAINT 1 0.0000
871 HAEMATEMESIS 1 0.0000
872 CARDIOVASCULAR DISORDER 1 0.0000
873 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
874 INFLAMMATION 2 0.0000
875 NO ADVERSE EVENT 7 0.0000
876 ECZEMA 2 0.0000
877 GASTRITIS 1 0.0000
878 NASOPHARYNGITIS 7 0.0000
879 EAR INFECTION 1 0.0000
880 BREAST CANCER FEMALE 1 0.0000
881 CARDIAC FAILURE CONGESTIVE 3 0.0000
882 THROMBOSIS 3 0.0000
883 DISTURBANCE IN ATTENTION 2 0.0000
884 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
885 LIMB INJURY 1 0.0000
886 MEMORY IMPAIRMENT 5 0.0000
887 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
888 ABNORMAL DREAMS 1 0.0000
889 ANAPHYLACTIC REACTION 2 0.0000
890 PROCEDURAL PAIN 1 0.0000
891 MEDICATION ERROR 2 0.0000
892 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
893 WEIGHT INCREASED 8 0.0000
894 RENAL IMPAIRMENT 3 0.0000
895 BLISTER 2 0.0000
896 EYE PAIN 2 0.0000
897 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
898 INCORRECT DOSE ADMINISTERED 8 0.0000
899 PRODUCT SUBSTITUTION ISSUE 2 0.0000
900 PRODUCT STORAGE ERROR 3 0.0000
901 ACUTE MYOCARDIAL INFARCTION 1 0.0000
902 LABORATORY TEST ABNORMAL 1 0.0000
903 CATARACT 2 0.0000
904 DEVICE ISSUE 3 0.0000
905 HEPATIC FAILURE 1 0.0000
906 LACRIMATION INCREASED 1 0.0000
907 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
908 CORONARY ARTERY DISEASE 1 0.0000
909 THERAPEUTIC RESPONSE DECREASED 2 0.0000
910 ILL-DEFINED DISORDER 2 0.0000
911 INJECTION SITE RASH 1 0.0000
912 ADVERSE EVENT 3 0.0000
913 NERVOUS SYSTEM DISORDER 1 0.0000
914 MOOD SWINGS 1 0.0000
915 METABOLIC ACIDOSIS 1 0.0000
916 HIP FRACTURE 1 0.0000
917 PAIN 19 0.0000
918 SWELLING FACE 2 0.0000
919 RENAL FAILURE 4 0.0000
920 ANGER 1 0.0000
921 PRODUCT QUALITY ISSUE 4 0.0000
922 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
923 HAEMOGLOBIN DECREASED 3 0.0000
924 HAEMATURIA 1 0.0000
925 HYPERKALAEMIA 1 0.0000
926 DEVICE MALFUNCTION 2 0.0000
927 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
928 CEREBRAL HAEMORRHAGE 1 0.0000
929 SKIN BURNING SENSATION 2 0.0000
930 CRYING 1 0.0000
931 HYPERGLYCAEMIA 1 0.0000
932 ACCIDENTAL OVERDOSE 1 0.0000
933 EYE SWELLING 1 0.0000
934 ASTHMA 3 0.0000
935 HALLUCINATION 2 0.0000
936 COLITIS 1 0.0000
937 CHRONIC KIDNEY DISEASE 2 0.0000
938 PALPITATIONS 3 0.0000
939 ABORTION SPONTANEOUS 1 0.0000
940 BLINDNESS 1 0.0000
941 ERYTHEMA 5 0.0000
942 CEREBROVASCULAR ACCIDENT 4 0.0000
943 MENTAL DISORDER 1 0.0000
944 MYOCARDIAL INFARCTION 4 0.0000
945 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
946 ANGIOEDEMA 1 0.0000
947 CHEST PAIN 4 0.0000
948 BREAST CANCER 2 0.0000
949 BLOOD CHOLESTEROL INCREASED 1 0.0000
950 CARDIAC DISORDER 2 0.0000
951 OCULAR HYPERAEMIA 1 0.0000
952 NEUROPATHY PERIPHERAL 2 0.0000
953 DISEASE RECURRENCE 1 0.0000
954 MULTIPLE SCLEROSIS 1 0.0000
955 HYPOGLYCAEMIA 1 0.0000
956 DRY EYE 1 0.0000
957 LEUKOPENIA 1 0.0000
958 SYNCOPE 2 0.0000
959 FLUID RETENTION 1 0.0000
960 NERVOUSNESS 1 0.0000
961 HAEMORRHAGE 2 0.0000
962 PLATELET COUNT DECREASED 2 0.0000
963 DRUG EFFECT DECREASED 1 0.0000
964 OVERDOSE 4 0.0000
965 HAEMATOCHEZIA 1 0.0000
966 ARTHROPATHY 1 0.0000
967 CONVULSION 1 0.0000
968 HERPES ZOSTER 1 0.0000
969 IRRITABILITY 1 0.0000
970 EMOTIONAL DISTRESS 2 0.0000
971 VISUAL IMPAIRMENT 2 0.0000
972 EXPOSURE DURING PREGNANCY 1 0.0000
973 DEVICE DIFFICULT TO USE 1 0.0000
974 INFUSION RELATED REACTION 1 0.0000
975 INJECTION SITE PRURITUS 1 0.0000
976 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
977 VISION BLURRED 2 0.0000
978 INFECTION 2 0.0000
979 INJECTION SITE SWELLING 1 0.0000
980 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
981 DRUG DOSE OMISSION 2 0.0000
982 ARTHRALGIA 5 0.0000
983 OROPHARYNGEAL PAIN 1 0.0000
984 MIGRAINE 1 0.0000
985 CONTUSION 1 0.0000
986 PSORIASIS 1 0.0000
987 INJECTION SITE PAIN 2 0.0000
988 BLOOD GLUCOSE INCREASED 1 0.0000